Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Si-Bone (SIBN) Capital Expenditures (2017 - 2025)

Si-Bone (SIBN) has 9 years of Capital Expenditures data on record, last reported at $1.3 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 250.29% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $8.4 million, up 1330.95%, while the annual FY2025 figure was $8.4 million, 1330.95% up from the prior year.
  • Capital Expenditures reached $1.3 million in Q4 2025 per SIBN's latest filing, down from $3.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $8.9 million in Q4 2022 and bottomed at -$6.2 million in Q4 2023.
  • Average Capital Expenditures over 5 years is $1.3 million, with a median of $2.0 million recorded in 2021.
  • Peak YoY movement for Capital Expenditures: skyrocketed 3700.0% in 2021, then tumbled 1100.54% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $5.9 million in 2021, then soared by 50.7% to $8.9 million in 2022, then tumbled by 169.61% to -$6.2 million in 2023, then surged by 86.19% to -$857000.0 in 2024, then skyrocketed by 250.29% to $1.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $1.3 million in Q4 2025, $3.0 million in Q3 2025, and $2.1 million in Q2 2025.